Latest Breaking News On - Marianne gillard - Page 1 : comparemela.com

Devastated. That is the word Professor Paul Young from the University of Queensland uses to describe the canning of Australia s most promising COVID-19 vaccine. Although the vaccine s revolutionary molecular clamp technology returned a robust immune response to coronavirus in 216 trial recipients in the Phase 1 trial, volunteers were warned that fragments of a protein derived from the HIV virus could produce antibodies, or a partial immune response to HIV. Although there was no possibility the participants could acquire HIV, the vaccine had the potential to interfere with existing HIV testing procedures. Dr Marianne Gillard, Minister Kate Jones, Professor of Virology Paul Young (centre), Dr Keith Chappell, and Dr Dan Watterson, in the Molecular Virology Lab. Picture: Liam Kidston

Sarah marshallGreg huntPaul youngAstra zenicaKate jonesScott morrisonAndrew nashMarianne gillardKeith chappellDan wattersonBrendan murphyNational biologics facilityMolecular virology labUniversity of queenslandTherapeutic goods administrationProfessor paul young